Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : PJ April 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Alfacalcidol, Maloxon and phenoxybenzamine out of stock Subscription

    30 MAR 2015 13:30

    The following products are currently out of stock from Amdipharm Mercury and are due back in stock by the end of April 2015: alfacalcidol capsules 0.25μg x 30 and 1μg x 30; Maloxon (metoclopramide hydrochloride) tablets 10mg x 84; and phenoxybenzamine capsules 10mg x 30.

  • Antibiotic-resistant infections Subscription

    13 APR 2015 16:50

    6 April 2015: Sky News reported on a new antibiotic resistant superbug and warned that drug resistant infections will continue to rise without new antibiotics. Speaking to the channel, Royal Pharmaceutical Society (RPS) spokesperson Jayne Lawrence said: “The pharmaceutical industry is not producing new antibiotics. There have been less than two new classes of antibiotics since the 1980s… so we need to incentivise industry to make more of them.”

  • First home HIV self-testing kit goes on sale in UK Subscription

    28 APR 2015 16:50

    The first HIV self-testing kit that is legally approved in the UK to give immediate results to users became available to buy online on 27 April 2015.

  • Speeding up the time it takes to register drugs, vaccines and diagnostics in low and middle income countries is a key strategy for the Bill and Melinda Gates Foundation. In the image, the headquarters of the foundation

    Gates Foundation aims to cut drug registration times by 50% in sub-Saharan Africa by 2018 Subscription

    7 APR 2015 12:54 By Ingrid Torjesen

    Speeding up the time it takes to register drugs, vaccines and diagnostics in low and middle income countries is a key strategy for the Bill and Melinda Gates Foundation.

  • ‘Lyme disease’, by Alan G. Barbour

    Improve your knowledge of Lyme disease Subscription

    8 APR 2015 15:57 By Larry Goodyer

    ‘Lyme disease’ by Alan G Barbour.

  • Glucose lowering drugs and weight gain might increase the risk of heart failure, say the authors of an analysis of data from 14 trials

    Jury still out on risk of heart failure from glucose lowering drugs Subscription

    2 APR 2015 16:53 By Janna Lawrence

    Clinicians have questioned trial data which indicate that glucose lowering drugs might increase the risk of heart failure.

  • Safeguarding patients against the risk of bleeding and the management of polypharmacy are vital roles for pharmacists when dealing with patients taking new oral anticoagulants (NOACs), according to speakers at the annual congress of the EAHP in Hamburg

    Managing the risk of bleeding with new oral anticoagulants Subscription

    20 APR 2015 13:34 By Christine Clark

    Safeguarding patients against the risk of bleeding is a vital role for pharmacists when dealing with patients taking new oral anticoagulants.

  • New dates for emergency supply of medicines audit Subscription

    17 MAR 2015 10:17

    The Pharmaceutical Services Negotiating Committee (PSNC), NHS England and NHS Employers have agreed that the national community pharmacy clinical audit on the emergency supply of medicines will now go ahead over two revised audit periods: 23 March 2015–5 April 2015 and 6 April 2015–19 April 2015. The audit was agreed as part of the ...

  • Paracetamol effectiveness questioned Subscription

    13 APR 2015 16:51

    1 April 2015: An Australian review was published, warning that paracetamol is ineffective at treating back pain and osteoarthritis. Speaking to BBC Online, Royal Pharmaceutical Society (RPS) spokesperson Roger Knaggs said: “There are other medicines, such as nonsteroidal anti-inflammatory drugs and opioids, which may provide better pain relief, but these are associated with a range of other side-effects. Anybody with concerns about whether taking paracetamol could cause harm should ...

  • Trials of antidepressants used to treat anxiety disorders that the US Food and Drug Administration deemed positive were more likely to be published than those deemed negative.

    Review identifies reporting bias in anxiety disorder trials Subscription

    13 APR 2015 16:43

    Trials of antidepressants used to treat anxiety disorders that the US Food and Drug Administration deemed positive were more likely to be published than those deemed negative.

Show  10 per page20 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.